Breast Cancer Trial, Recruiting NCT07478900 Sponsor: All India Institute of Medical Sciences, Bhubaneswar Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07478900
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 75 years of age
  • People who have been diagnosed with breast cancer confirmed through a biopsy
  • People with a breast tumour of a certain size (classified as T2 or T3) who are planned to receive chemotherapy before surgery
  • People who have a breast tumour that can be felt by touch and is suitable for a marking procedure to identify its location
  • People whose treatment plan includes a type of surgery that removes the tumour while preserving most of the breast, following chemotherapy
  • People who are able and willing to sign a written consent form to participate

Who may not be able to join:

  • People with a known allergy or sensitivity to the materials used in tattooing, which is the method used to mark the tumour location in this trial
  • People with early-stage breast cancer that does not require chemotherapy before surgery
  • People diagnosed with inflammatory breast cancer (a specific type where the breast becomes red and swollen)
  • People with a larger tumour (T3) and a small breast size, or those with a T4 tumour (one that has grown into the chest wall or skin)
  • People who are not willing to have the type of surgery that preserves most of the breast
  • People whose mammogram shows a widespread scattering of tiny calcium deposits throughout the breast tissue
  • People diagnosed with ductal carcinoma in situ (an early, non-invasive form of breast cancer)
  • Men with breast cancer
  • People whose cancer is found in more than one separate area of the breast
  • People whose tumour is located in a position that makes breast-preserving surgery not possible
  • People whose breast cancer has come back after previous treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +919438884252

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Registry
ClinicalTrials.gov
Start date
10 September 2025
Est. completion
9 September 2027

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Complete excision of breast tumor with negative histopathological margins (R0 Resection); Complete Pathological Excision of the Breast Tumor (R0 Resection)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov